The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus

Journal of Experimental Medicine

Volumn 206, Issue 12, 2009, Pages 2685-2699

  Zamisch, Monica ^a   Tian, Linhua ^a,d   Grenningloh, Roland ^b,e   Xiong, Yumei ^a   Wildt, Kathryn F ^a   Ehlers, Marc ^c   Ho, I Cheng ^b   Bosselut, Rémy ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^d BRISTOL MYERS SQUIBB   (United States)

^e Merck Serono GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOTOXIC FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR RUNX3; ETS1 PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; RUNX3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; THYMOCYTE; THYMUS; ANIMAL; CYTOLOGY; DNA RESPONSIVE ELEMENT; GENETICS; IMMUNOLOGY; MOUSE MUTANT; UPREGULATION;

ANIMALS; ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEIN C-ETS-1; RESPONSE ELEMENTS; THYMUS GLAND; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 73349107484     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20092024     Document Type: Article

References (68)

1. Anderson, M.K., G. Hernandez-Hoyos, R.A. Diamond, and E.V. Rothenberg. 1999. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 126: 3131-3148.
2. Arman, M., J. Calvo, M.E. Trojanowska, P.N. Cockerill, M. Santana, M. López-Cabrera, J. Vives, and F. Lozano. 2004. Transcriptional regulation of human CD5: important role of Ets transcription factors in CD5 expression in T cells. J. Immunol. 172: 7519-7529.
3. Barnden, M.J., J. Allison, W.R. Heath, and F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40. doi:10.1046/j.1440-1711 .1998.00709.x
4. Barton, K., and G. Nucifora. 2000. AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia. Bioessays. 22: 214-218. doi:10.1002/ (SICI)1521-1878(200003)22:3〈214::AID-BIES2〉3.0.CO;2-I
5. Barton, K., N. Muthusamy, C. Fischer, C.N. Ting, T.L. Walunas, L.L. Lanier, and J.M. Leiden. 1998. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 9: 555-563. doi:10.1016/S1074-7613(00)80638-X
6. Bories, J.C., D.M. Willerford, D. Grévin, L. Davidson, A. Camus, P. Martin, D. Stéhelin, and F.W. Alt. 1995. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 377: 635-638. doi:10.1038/377635a0
7. Bosselut, R. 2004. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4: 529-540. doi:10.1038/nri1392
8. Brugnera, E., A. Bhandoola, R. Cibotti, Q. Yu, T.I. Guinter, Y. Yamashita, S.O. Sharrow, and A. Singer. 2000. Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells. Immunity. 13: 59-71. doi:10.1016/S1074-7613(00)00008-X
9. Clements, J.L., S.A. John, and L.A. Garrett-Sinha. 2006. Impaired generation of CD8+ thymocytes in Ets-1-deficient mice. J. Immunol. 177: 905-912.
10. Cruz-Guilloty, F., M.E. Pipkin, I.M. Djuretic, D. Levanon, J. Lotem, M.G. Lichtenheld, Y. Groner, and A. Rao. 2009. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206: 51-59. doi:10.1084/jem.20081242
11. Djuretic, I.M., D. Levanon, V. Negreanu, Y. Groner, A. Rao, and K.M. Ansel. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8: 145-153. doi:10.1038/ni1424
12. Egawa, T., and D.R. Littman. 2008. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat. Immunol. 9: 1131-1139. doi:10.1038/ni.1652
13. Egawa, T., R.E. Tillman, Y. Naoe, I. Taniuchi, and D.R. Littman. 2007. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204: 1945-1957. doi:10.1084/jem.20070133
14. Ehlers, M., K. Laule-Kilian, M. Petter, C.J. Aldrian, B. Grueter, A. Würch, N. Yoshida, T. Watanabe, M. Satake, and V. Steimle. 2003. Morpholino antisense oligonucleotide-mediated gene knockdown during thymocyte development reveals role for Runx3 transcription factor in CD4 silencing during development of CD4-/CD8+ thymocytes. J. Immunol. 171: 3594-3604.
15. Erman, B., M. Cortes, B.S. Nikolajczyk, N.A. Speck, and R. Sen. 1998. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol. Cell. Biol. 18: 1322-1330.
16. Eyquem, S., K. Chemin, M. Fasseu, and J.C. Bories. 2004. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus. Proc. Natl. Acad. Sci. USA. 101: 15712-15717. doi:10.1073/pnas.0405546101
17. Fowlkes, B.J., and D.M. Pardoll. 1989. Molecular and cellular events of T cell development. Adv. Immunol. 44: 207-264. doi:10.1016/S0065-2776(08) 60643-4
18. Goetz, T.L., T.L. Gu, N.A. Speck, and B.J. Graves. 2000. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Mol. Cell. Biol. 20: 81-90. doi:10.1128/MCB.20.1.81-90.2000
19. Grenningloh, R., B.Y. Kang, and I.C. Ho. 2005. Ets-1, a functional cofactor of T-bet, is essential for Th1 infl ammatory responses. J. Exp. Med. 201: 615-626. doi:10.1084/jem.20041330
20. Grenningloh, R., S.C. Miaw, J. Moisan, B.J. Graves, and I.C. Ho. 2008. Role of Ets-1 phosphorylation in the effector function of Th cells. Eur. J. Immunol. 38: 1700-1705. doi:10.1002/eji.200738112
21. Grueter, B., M. Petter, T. Egawa, K. Laule-Kilian, C.J. Aldrian, A. Wuerch, Y. Ludwig, H. Fukuyama, H. Wardemann, R. Waldschuetz, et al. 2005. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells. J. Immunol. 175: 1694-1705.
22. Gu, T.L., T.L. Goetz, B.J. Graves, and N.A. Speck. 2000. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1). Mol. Cell. Biol. 20: 91 -103. doi:10.1128/MCB.20.1.91-103.2000
23. He, X., X. He, V.P. Dave, Y. Zhang, X. Hua, E. Nicolas, W. Xu, B.A. Roe, and D.J. Kappes. 2005. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature. 433: 826-833. doi:10.1038/nature03338
24. Hernández-Hoyos, G., M.K. Anderson, C. Wang, E.V. Rothenberg, and J. Alberola-Ila. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity. 19: 83-94. doi:10.1016/ S1074-7613(03)00176-6
25. Higuchi, T., F.O. Bartel, M. Masuya, T. Deguchi, K.W. Henderson, R. Li, R.C. Muise-Helmericks, M.J. Kern, D.K. Watson, and D.D. Spyropoulos. 2007. Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice. Mol. Cell. Biol. 27: 3353-3366. doi:10.1128/MCB.01871-06
26. Ho, I.C., N.K. Bhat, L.R. Gottschalk, T. Lindsten, C.B. Thompson, T.S. Papas, and J.M. Leiden. 1990. Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer. Science. 250: 814-818. doi:10.1126/ science.2237431
27. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76: 17-27. doi:10.1016/0092-8674(94)90169-4
28. Hollenhorst, P.C., A.A. Shah, C. Hopkins, and B.J. Graves. 2007. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev. 21: 1882-1894. doi:10.1101/gad .1561707
29. Jenkinson, S.R., A.M. Intlekofer, G. Sun, L. Feigenbaum, S.L. Reiner, and R. Bosselut. 2007. Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation. J. Exp. Med. 204: 267-272. doi:10.1084/jem .20061982
30. Kim, W.Y., M. Sieweke, E. Ogawa, H.J. Wee, U. Englmeier, T. Graf, and Y. Ito. 1999. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18: 1609-1620. doi:10.1093/emboj/18.6.1609
31. Kioussis, D., and W. Ellmeier. 2002. Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation. Nat. Rev. Immunol. 2: 909-919. doi:10.1038/nri952
32. Kishimoto, H., and J. Sprent. 1999. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190: 65-73. doi:10.1084/jem.190.1.65
33. Klug, D.B., C. Carter, E. Crouch, D. Roop, C.J. Conti, and E.R. Richie. 1998. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc. Natl. Acad. Sci. USA. 95: 11822-11827. doi:10.1073/pnas.95.20.11822
34. Kohu, K., T. Sato, S. Ohno, K. Hayashi, R. Uchino, N. Abe, M. Nakazato, N. Yoshida, T. Kikuchi, Y. Iwakura, et al. 2005. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J. Immunol. 174: 2627-2636.
35. Liu, X., and R. Bosselut. 2004. Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat. Immunol. 5: 280-288. doi:10.1038/ ni1040
36. Liu, X., A. Adams, K.F. Wildt, B. Aronow, L. Feigenbaum, and R. Bosselut. 2003. Restricting Zap70 expression to CD4+CD8+ thymocytes reveals a T cell receptor-dependent proofreading mechanism controlling the completion of positive selection. J. Exp. Med. 197: 363-373. doi:10.1084/jem.20021698
37. Muroi, S., Y. Naoe, C. Miyamoto, K. Akiyama, T. Ikawa, K. Masuda, H. Kawamoto, and I. Taniuchi. 2008. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat. Immunol. 9: 1113-1121. doi:10.1038/ni.1650
38. Muthusamy, N., K. Barton, and J.M. Leiden. 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 377: 639-642. doi:10.1038/377639a0
39. Naoe, Y., R. Setoguchi, K. Akiyama, S. Muroi, M. Kuroda, F. Hatam, D.R. Littman, and I. Taniuchi. 2007. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbfβ binding to the Il4 silencer. J. Exp. Med. 204: 1749-1755. doi:10.1084/jem.20062456
40. Pai, S.Y., M.L. Truitt, C.N. Ting, J.M. Leiden, L.H. Glimcher, and I.C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity. 19: 863-875. doi:10.1016/S1074-7613(03)00328-5
41. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342: 559-561. doi:10.1038/342559a0
42. Pognonec, P., K.E. Boulukos, R. Bosselut, C. Boyer, A.M. Schmitt-Verhulst, and J. Ghysdael. 1990. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises. Oncogene. 5: 603-610.
43. Prosser, H.M., D. Wotton, A. Gegonne, J. Ghysdael, S. Wang, N.A. Speck, and M.J. Owen. 1992. A phorbol ester response element within the human T-cell receptor beta-chain enhancer. Proc. Natl. Acad. Sci. USA. 89: 9934-9938. doi:10.1073/pnas.89.20.9934
44. Pufall, M.A., G.M. Lee, M.L. Nelson, H.S. Kang, A. Velyvis, L.E. Kay, L.P. McIntosh, and B.J. Graves. 2005. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science. 309: 142-145. doi:10.1126/science.1111915
45. Sato, T., S. Ohno, T. Hayashi, C. Sato, K. Kohu, M. Satake, and S. Habu. 2005. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity. 22: 317-328. doi:10.1016/j.immuni.2005.01.012
46. Sawada, S., J.D. Scarborough, N. Killeen, and D.R. Littman. 1994. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell. 77: 917-929. doi:10.1016/ 0092-8674(94)90140-6
47. Setoguchi, R., M. Tachibana, Y. Naoe, S. Muroi, K. Akiyama, C. Tezuka, T. Okuda, and I. Taniuchi. 2008. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science. 319: 822-825. doi:10.1126/science.1151844
48. Shaner, N.C., P.A. Steinbach, and R.Y. Tsien. 2005. A guide to choosing fl uorescent proteins. Nat. Methods. 2: 905-909. doi:10.1038/ nmeth819
49. Sharrocks, A.D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2: 827-837. doi:10.1038/35099076
50. Singer, A., and R. Bosselut. 2004. CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv. Immunol. 83: 91-131. doi:10.1016/S0065-2776(04) 83003-7
51. Singer, A., S. Adoro, and J.H. Park. 2008. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8: 788-801. doi:10.1038/nri2416
52. Starr, T.K., S.C. Jameson, and K.A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21: 139-176. doi:10.1146/annurev .immunol.21.120601.141107
53. Sun, G., X. Liu, P. Mercado, S.R. Jenkinson, M. Kypriotou, L. Feigenbaum, P. Galéra, and R. Bosselut. 2005. The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat. Immunol. 6: 373-381. doi:10.1038/ni1183
54. Suzuki, H., J.A. Punt, L.G. Granger, and A. Singer. 1995. Asymmetric signaling requirements for thymocyte commitment to the CD4+ versus CD8+ T cell lineages: a new perspective on thymic commitment and selection. Immunity. 2: 413-425. doi:10.1016/1074-7613(95)90149-3
55. Swat, W., M. Dessing, H. von Boehmer, and P. Kisielow. 1993. CD69 expression during selection and maturation of CD4+8+ thymocytes. Eur. J. Immunol. 23: 739-746. doi:10.1002/eji.1830230326
56. Takahama, Y. 2006. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6: 127-135. doi:10.1038/ nri1781
57. Taniuchi, I., M. Osato, T. Egawa, M.J. Sunshine, S.C. Bae, T. Komori, Y. Ito, and D.R. Littman. 2002a. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 111: 621-633. doi:10.1016/S0092-8674(02) 01111-X
58. Taniuchi, I., M.J. Sunshine, R. Festenstein, and D.R. Littman. 2002b. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol. Cell. 10: 1083-1096.
59. Taniuchi, I., W. Ellmeier, and D.R. Littman. 2004. The CD4/CD8 lineage choice: new insights into epigenetic regulation during T cell development. Adv. Immunol. 83: 55-89. doi:10.1016/S0065-2776(04)83002-5
60. Telfer, J.C., E.E. Hedblom, M.K. Anderson, M.N. Laurent, and E.V. Rothenberg. 2004. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 172: 4359-4370.
61. Tung, J.W., S.S. Kunnavatana, L.A. Herzenberg, and L.A. Herzenberg. 2001. The regulation of CD5 expression in murine T cells. BMC Mol. Biol. 2: 5. doi:10.1186/1471-2199-2-5
62. Verger, A., and M. Duterque-Coquillaud. 2002. When Ets transcription factors meet their partners. Bioessays. 24: 362-370. doi:10.1002/bies. 10068
63. Wang, L., and R. Bosselut. 2009. CD4-CD8 lineage differentiation: Thpoking into the nucleus. J. Immunol. 183: 2903-2910. doi:10.4049/jimmunol .0901041
64. Wang, L., K.F. Wildt, J. Zhu, X. Zhang, L. Feigenbaum, L. Tessarollo, W.E. Paul, B.J. Fowlkes, and R. Bosselut. 2008a. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+) T cells. Nat. Immunol. 9: 1122-1130. doi:10.1038/ni.1647
65. Wang, L., K.F. Wildt, E. Castro, Y. Xiong, L. Feigenbaum, L. Tessarollo, and R. Bosselut. 2008b. The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity. 29: 876-887. doi:10.1016/j.immuni.2008.09.019
66. Wildt, K.F., G. Sun, B. Grueter, M. Fischer, M. Zamisch, M. Ehlers, and R. Bosselut. 2007. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J. Immunol. 179: 4405-4414.
67. Woolf, E., C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, et al. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA. 100: 7731-7736. doi:10.1073/pnas.1232420100
68. Yu, Q., B. Erman, A. Bhandoola, S.O. Sharrow, and A. Singer. 2003. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J. Exp. Med. 197: 475-487. doi:10.1084/jem.20021765